Original news and analysis on international IP policy
Executive Director Ellen 't Hoen is departing the Medicines Patent Pool, the cutting edge UN spin-off project that works to lower prices on and stimulate new development of HIV medicines and other products through negotiating voluntary licence agreements. According to a release, 't Hoen has fulfilled the mission of guiding the organisation from a startup onto "firm footing" and has informed the Board that she will leave on 1 May.
The United States is known for taking an unusually expansive approach towards patentable subject matter. Compared with Western Europe, for instance, the US has been far readier to grant patents on business methods, medical diagnostic processes, and human genes.
A new treaty protocol against illicit trade in tobacco products struck today at the World Health Organization saw a late-stage decision to strip out references to “counterfeit” products from the text, according to sources.
Honduras announced today it has requested formal consultations with Australia under the World Trade Organization dispute settlement procedures, charging that Australia's public health law requiring tobacco to be sold in plain packaging violates the WTO intellectual property agreement.
A new report by civil society group No Patent on Seeds was issued yesterday alleging that industry and patent examiners in the European Patent Office are "using legal loopholes to grant patents on seeds, plants and even harvest and food products derived thereof."
Using on-the-ground research in Africa and the Netherlands, the authors of a recent book looked at the impact of intellectual property on agriculture and health in developing countries. The study made some surprise findings in relation to IP and development, such as IP-related obstacles to knowledge and technology transfer.
The latest World Health Organization / European Union plans to counter the trade in counterfeit and substandard medicines aim to ensure that medicines in the developing world are safe. As such, though both plans appropriately address quality issues, they fall short of adequate coordination and collaboration with each other, and also present substantial flaws, Daniele Dionisio writes.
The Indian Supreme Court today postponed hearing the high-profile case involving Swiss pharmaceutical producer Novartis' challenge of India's patent law until July, according to sources.
The United States Supreme Court yesterday threw out a high-profile case that had allowed a private company's patents on two human genes associated with cancer.
The head of the West Africa region for the Global Fund to Fight AIDS, Tuberculosis and Malaria is the next in the line of departures under the organisation’s reforms. On the way out, he sent around a passionate farewell email calling for a dedication to values, and offering a small window on the wrenching transition taking place inside the international organisation.
World Health Organization Director-General Margaret Chan has issued a call for global support of Australia in defending its “plain packaging” tobacco law against an onslaught of legal challenges from the tobacco industry. The industry has cited trademark concerns as a top issue.
On 20 March, the US Supreme Court cut back on the types of inventions that can be patented in America. The court held in Mayo Collaborative Services v. Prometheus Labs., Inc. that one cannot patent an invention which merely applies known technology to natural phenomena.